Amdocs Limited $DOX Shares Bought by Boothbay Fund Management LLC

Boothbay Fund Management LLC grew its holdings in shares of Amdocs Limited (NASDAQ:DOX) by 50.7% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 286,069 shares of the technology company’s stock after buying an additional 96,229 shares during the period. Amdocs accounts for about 0.3% of Boothbay Fund Management LLC’s holdings, making the stock its 18th largest holding. Boothbay Fund Management LLC owned about 0.25% of Amdocs worth $23,472,000 as of its most recent SEC filing.

Other hedge funds have also made changes to their positions in the company. Scotia Capital Inc. lifted its stake in Amdocs by 3.5% during the third quarter. Scotia Capital Inc. now owns 4,289 shares of the technology company’s stock worth $352,000 after purchasing an additional 145 shares during the last quarter. CENTRAL TRUST Co increased its stake in Amdocs by 6.1% in the third quarter. CENTRAL TRUST Co now owns 2,741 shares of the technology company’s stock valued at $225,000 after purchasing an additional 158 shares during the last quarter. WealthCollab LLC increased its stake in Amdocs by 94.5% in the third quarter. WealthCollab LLC now owns 356 shares of the technology company’s stock valued at $29,000 after purchasing an additional 173 shares during the last quarter. Rossby Financial LCC raised its holdings in Amdocs by 39.3% during the third quarter. Rossby Financial LCC now owns 620 shares of the technology company’s stock worth $50,000 after purchasing an additional 175 shares in the last quarter. Finally, AE Wealth Management LLC raised its holdings in Amdocs by 4.5% during the second quarter. AE Wealth Management LLC now owns 4,096 shares of the technology company’s stock worth $374,000 after purchasing an additional 177 shares in the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Price Performance

DOX stock opened at $66.34 on Friday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. The company has a market capitalization of $7.16 billion, a P/E ratio of 12.83, a PEG ratio of 1.17 and a beta of 0.42. The business has a 50 day simple moving average of $75.08 and a 200-day simple moving average of $79.18. Amdocs Limited has a twelve month low of $65.39 and a twelve month high of $95.41.

Amdocs (NASDAQ:DOX) last announced its earnings results on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, beating analysts’ consensus estimates of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion for the quarter, compared to analysts’ expectations of $1.15 billion. During the same period in the previous year, the company posted $1.66 EPS. The company’s quarterly revenue was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS. As a group, equities analysts anticipate that Amdocs Limited will post 6.21 EPS for the current year.

Amdocs Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be issued a $0.569 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.4%. Amdocs’s dividend payout ratio is currently 40.81%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on DOX shares. Barclays lowered their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating for the company in a report on Wednesday, February 4th. Wall Street Zen raised shares of Amdocs from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Weiss Ratings restated a “hold (c)” rating on shares of Amdocs in a research note on Tuesday, January 27th. Finally, Stifel Nicolaus dropped their price objective on Amdocs from $97.00 to $88.00 and set a “buy” rating on the stock in a report on Wednesday, February 4th. Three investment analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $92.33.

About Amdocs

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.